ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 21:20 (676 d 23:23 ago) – Posting: # 20047
Views: 3,196

Hi Helmut,

Thank you so much for the detailed answer!

» » Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

» Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,310 posts in 4,445 threads, 1,489 registered users;
online 5 (0 registered, 5 guests [including 3 identified bots]).
Forum time: Saturday 20:43 UTC (Europe/Vienna)

Any sufficiently advanced technology
is indistinguishable from magic.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5